Related Experiment Video

Updated: Jul 17, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer

Frederic J Kaye1

  • 1Genetics Branch, Center for Cancer Research, NCI, NIH and National Naval Medical Center, Bethesda, Maryland 20889, USA. fkaye@helix.nih.gov

Oncogene
|October 4, 2002
PubMed

Insights

The RB:p16 tumor suppressor pathway is crucial in lung cancer development, with genetic alterations driving tumor growth. Understanding RB

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RB:CDK:cyclin:p16 pathway is frequently altered in human cancers.
  • Lung cancer research has elucidated the role of RB and the RB:p16 pathway in tumorigenesis.
  • Lung cancer development involves complex, multi-step genetic alterations due to carcinogen exposure.

Purpose of the Study:

  • To investigate the genetic and epigenetic alterations in the RB:CDK:cyclin:p16 tumor suppressor pathway in human cancers.
  • To understand the role of RB pathway components in lung cancer genesis and progression.
  • To explore the multifunctional properties of RB in regulating cell proliferation, differentiation, and apoptosis in the context of lung cancer subtypes.

Main Methods:

  • Analysis of genetic and epigenetic alterations in tumor suppressor genes.
  • Utilizing lung cancer as a model system to study RB pathway involvement.
  • Investigating the relationship between RB's regulatory functions and clonal gene defects.

Main Results:

  • The RB:CDK:cyclin:p16 pathway is a critical target for inactivation by viral oncoproteins.
  • Lung cancer demonstrated the significance of RB and a multi-component RB:p16 pathway in malignancy.
  • Lung tumorigenesis requires cumulative somatic alterations across multiple genetic loci.

Conclusions:

  • Understanding RB's multifaceted roles is essential for deciphering lung cancer subtype-specific gene inactivation patterns.
  • Elucidating these pathways is key to realizing the potential of molecularly targeted therapies for lung cancer.
  • Further research into RB pathway regulation and its interplay with other genetic defects will advance cancer treatment strategies.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...